Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Joel, Kallich"'
Autor:
Shanmugapriya Reddy, Fenglong Xie, W. Benjamin Nowell, Michael D. George, Maria I. Danila, Daniel Watrous, Joel Kallich, Jeffrey Alper, Jeffrey R. Curtis, Cassie Clinton, Kenneth G. Saag
Publikováno v:
Arthritis Care & Research
The effect of the COVID-19 pandemic on community-based rheumatology care and the use of telehealth is unclear. We undertook this study to investigate the impact of the pandemic on rheumatology care delivery in a large community practice-based network
Autor:
Ron D. Hays, Sheryl A. Kingsberg, Michelle Z. Lim-Watson, Irene B. Murimi-Worstell, Joel Kallich
Publikováno v:
Sexual medicine reviews. 10(1)
Introduction Hypoactive Sexual Desire Disorder (HSDD) / Female Sexual Interest/Arousal Disorder (FSIAD) impacts health-related quality of life (HRQoL) of women and their partners, yet existing measures fail to adequately capture relevant concepts (ie
Publikováno v:
BMC nephrology, vol 20, iss 1
BMC Nephrology
BMC Nephrology, Vol 20, Iss 1, Pp 1-3 (2019)
BMC Nephrology
BMC Nephrology, Vol 20, Iss 1, Pp 1-3 (2019)
A recent article in the journal reported analyses of KDQOL-36™ survey data collected from 240,343 adults (330,412 surveys) dialyzed at a large dialysis organization in the United States during 2014–2016. The authors concluded that the KDQOL-36™
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df719ff5a573b258f3ecd5e860f79d0e
https://escholarship.org/uc/item/1dx0z7ws
https://escholarship.org/uc/item/1dx0z7ws
Publikováno v:
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-10 (2019)
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-10 (2019)
Introduction Biosimilar infliximab has the potential for appreciable cost savings compared to its reference biologic, but dose escalation is common and increases costs. We compared frequency of dose escalation and associated Medicare-approved amount
Autor:
Emma R. Oppenheim, Jodi B Segal, G. Caleb Alexander, Louis P. Garrison, Marla Kessler, Joel Kallich, Sheikh Usman Iqbal
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 22:191-196
Most randomized controlled trials are unable to generate information about a product's real-world effectiveness. Therefore, payers use real-world evidence (RWE) generated in observational studies to make decisions regarding formulary inclusion and co
Autor:
Ron D. Hays, Y. Tang, B. Mahadik, I.B. Murimi, M.Z. Lim-Watson, J. Doucette, Joel Kallich, S. Kingsberg
Publikováno v:
Value in Health. 23:S164
Publikováno v:
Value in Health. 23:S322
Publikováno v:
The Journal of Community and Supportive Oncology. 12:163-170
Autor:
Qian Cai, Hema N. Viswanathan, Sally W. Wade, Bradley S. Stolshek, Akhila Balasubramanian, John L. Adams, Jeffrey R. Curtis, Joel Kallich
Publikováno v:
Bone. 55:1-6
Few data are available on physician perceptions of osteoporosis medication adherence. This study compared physician-estimated medication adherence with adherence calculated from their patients' pharmacy claims. Women aged ≥45 years, with an osteopo
Autor:
Jeffrey White, Hema N. Viswanathan, Akhila Balasubramanian, Claire Merinar, Jeffrey R. Curtis, Bradley S. Stolshek, Sally W. Wade, John L. Adams, Jingbo Yu, Joel Kallich
Publikováno v:
Applied Health Economics and Health Policy. 10:163-173
Background:Background: Osteoporosis is a common condition and the economic burden of osteoporosis-related fractures is significant. While studies have reported the incremental or attributable costs of osteoporosis-related fracture, data on the econom